Correct me if I am wrong but Lupin study did not use 400mg dosage. It does seem DARRT could give a similar response rate but I guess only Nox can tell us that.
The Lupin trial is a significant result. Would have been nice to show the percentage of abscopal.
Also would have been nice to show how many are still alive in DARRT. They used to post detailed figures per patient.
I can sense some takeover in the near future.
Ann: ASCO 2020 Highlights NOX66 Potential in Late-Stage Cancer, page-3
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.8¢ |
Change
-0.013(10.4%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 10.8¢ | $21.50K | 195.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 120885 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 39408 | 1 |
View Market Depth
| Last trade - 14.53pm 13/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |